JSE LIMITED - Dealings in securities by directors, the company secretary and the JSE LTIS 2018 Trust

Release Date: 20/09/2018 17:41
Code(s): JSE
Wrap Text
Dealings in securities by directors, the company secretary and the JSE LTIS 2018 Trust

JSE Limited
(Incorporated in the Republic of South Africa)
(Registration number: 2005/022939/06)
ISIN: ZAE000079711
Share Code: JSE
("JSE" or “the Company”)


The JSE LTIS 2018 Trust ("Trust") has acquired 175 820 JSE ordinary
shares in the open market on behalf of executive directors, members of
the   executive  committee   and  the   Company Secretary ("LTIS  2018
participants") to fulfil share awards granted to these staff under the
JSE’s Long-Term Incentive Scheme ("LTIS 2018").

These ordinary shares are held in trust and are restricted until all
vesting criteria are fulfilled whereupon the shares vest. To the extent
that the vesting criteria are not fulfilled the share awards are

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) a LTIS 2018 participant remaining in the employ of the JSE for the
     vesting term (collectively "the vesting criteria").

These JSE ordinary shares were acquired on-market, with clearance, at a
volume-weighted average price of R153.75 per ordinary share. The total
transaction value amounted to R27 032 325. The daily high, low and
volume-weighted average for the various transactions were –

 Dates in 2018
    that JSE       Number of JSE                Daily high    Daily low
    ordinary         ordinary     Daily VWAP    price paid    price paid
     shares           shares      (cents per    (cents per   (cents per             
    acquired         acquired       share)        share)        share)    

 14 September        51 983         15222          15375        15149

 17 September        96 176         15391          15525        15200

 18 September        19 901         15582          15628        15505

 19 September        7 760          15663          15670        15599

The requisite approvals have been granted by shareholders at the
Company’s annual general meeting, in respect of the acquisition of JSE
ordinary shares in the open market and in respect of specific financial
assistance to the Trust for the purpose of acquiring these shares.


Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, members of the JSE’s executive committee, which includes
the executive directors, and the Company Secretary, have on 18 September
2018 accepted grants of restricted ordinary shares in the Company, as
reflected in this announcement.

                                      Total number
                                      of restricted      Total Rand value
                                      JSE ordinary       of restricted JSE
                                         shares           ordinary shares   
                                      awarded and          awarded and        Nature of
   Executive           Role             accepted            accepted           interest
  NF Newton-King   CEO & Executive      52 040               8 001 150         Direct
                   Director                                                  beneficial
  A Takoordeen     CFO & Executive      16 680               2 564 550         Direct
                   Director                                                  beneficial
  JH Burke         Alternate            18 390               2 827 462         Direct
                   Director                                                  beneficial
  A Greenwood      Prescribed           17 750               2 729 062         Direct
                   Officer                                                   beneficial
  D Khumalo        Prescribed           13 170               2 024 887         Direct
                   Officer                                                   beneficial
  DM Nemer         Prescribed           20 240               3 111 900         Direct
                   Officer                                                   beneficial
  M Randall        Prescribed           13 900               2 137 125         Direct
                   Officer                                                   beneficial
  ZA Jacobs        Prescribed           15 920               2 447 700         Direct
                   Officer                                                   beneficial
  GA Brookes       Group Company         7 730               1 188 487         Direct
                   Secretary                                                 beneficial

The restricted shares will vest in two tranches, one-half on 31 August
2021 and the remaining half on 31 August 2022, subject to the vesting
criteria as set out above being met.

The individual allocations (grant and acceptance) were approved by the
JSE’s Group Human Resources Committee and clearance to deal was granted
by the Chairman of the Board.

20 September 2018

RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 20/09/2018 05:41:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story